LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 196 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $880 | +44.0% | 14,690 | +73.3% | 0.01% | +100.0% |
| Q2 2023 | $611 | -65.1% | 8,475 | -64.4% | 0.01% | -75.0% |
| Q1 2023 | $1,749 | -30.8% | 23,783 | -37.1% | 0.02% | -35.5% |
| Q4 2022 | $2,528 | -99.6% | 37,838 | +371.6% | 0.03% | +287.5% |
| Q2 2022 | $716,000 | +11.7% | 8,024 | +40.8% | 0.01% | +60.0% |
| Q1 2022 | $641,000 | -51.2% | 5,699 | -33.0% | 0.01% | -28.6% |
| Q4 2021 | $1,314,000 | +276.5% | 8,506 | +239.7% | 0.01% | +250.0% |
| Q3 2021 | $349,000 | -60.4% | 2,504 | -62.7% | 0.00% | -50.0% |
| Q2 2021 | $881,000 | +19.4% | 6,718 | +38.7% | 0.00% | 0.0% |
| Q1 2021 | $738,000 | -42.3% | 4,843 | -62.3% | 0.00% | -42.9% |
| Q4 2020 | $1,279,000 | +64.0% | 12,859 | +57.1% | 0.01% | +40.0% |
| Q3 2020 | $780,000 | -37.7% | 8,185 | -26.9% | 0.01% | -50.0% |
| Q2 2020 | $1,252,000 | +159.2% | 11,193 | +68.6% | 0.01% | +100.0% |
| Q1 2020 | $483,000 | -57.4% | 6,637 | -39.0% | 0.01% | -50.0% |
| Q4 2019 | $1,134,000 | +687.5% | 10,877 | +652.2% | 0.01% | +900.0% |
| Q3 2019 | $144,000 | -58.0% | 1,446 | -51.9% | 0.00% | -50.0% |
| Q2 2019 | $343,000 | -56.6% | 3,009 | -52.1% | 0.00% | -71.4% |
| Q1 2019 | $790,000 | -60.2% | 6,284 | -57.1% | 0.01% | -58.8% |
| Q4 2018 | $1,987,000 | +53.0% | 14,644 | +209.3% | 0.02% | +70.0% |
| Q3 2018 | $1,299,000 | -39.2% | 4,734 | -54.1% | 0.01% | -47.4% |
| Q2 2018 | $2,137,000 | +880.3% | 10,316 | +680.3% | 0.02% | +850.0% |
| Q1 2018 | $218,000 | +50.3% | 1,322 | +25.0% | 0.00% | +100.0% |
| Q4 2017 | $145,000 | -75.8% | 1,058 | -76.0% | 0.00% | -80.0% |
| Q3 2017 | $600,000 | +119.0% | 4,404 | +95.0% | 0.01% | +150.0% |
| Q2 2017 | $274,000 | -22.4% | 2,258 | -32.4% | 0.00% | -33.3% |
| Q1 2017 | $353,000 | -62.6% | 3,339 | -64.0% | 0.00% | -62.5% |
| Q4 2016 | $943,000 | +265.5% | 9,276 | +266.6% | 0.01% | +166.7% |
| Q3 2016 | $258,000 | +84.3% | 2,530 | +93.9% | 0.00% | +200.0% |
| Q1 2016 | $140,000 | -17.2% | 1,305 | -16.1% | 0.00% | 0.0% |
| Q4 2015 | $169,000 | -29.3% | 1,555 | -44.2% | 0.00% | 0.0% |
| Q3 2015 | $239,000 | -33.2% | 2,786 | -40.1% | 0.00% | -50.0% |
| Q1 2015 | $358,000 | 0.0% | 4,649 | -30.9% | 0.00% | 0.0% |
| Q4 2014 | $358,000 | +39.3% | 6,729 | +63.4% | 0.00% | +100.0% |
| Q2 2014 | $257,000 | +97.7% | 4,118 | +37.4% | 0.00% | 0.0% |
| Q3 2013 | $130,000 | -14.5% | 2,996 | -26.2% | 0.00% | 0.0% |
| Q2 2013 | $152,000 | – | 4,062 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |